Researchers have shown that cannabidiol (CBD), a compound found in cannabis, did not provide any additional benefit in treating severe behavioral disorders in children with intellectual disabilities, compared to a placebo.
Hot Topics
According to the study published in JAMA Pediatrics, children who received CBD oil daily for 8 weeks did not show greater improvement in aggressive behavior, irritability, self-harm, anxiety, sleep, or social withdrawal compared to the group that received a placebo.
The trial included 131 children and adolescents aged 6 to 18 from three children's hospitals in Australia. Participants were randomly divided into two groups, without the children, their families, or their doctors knowing who received CBD and who received a placebo, in a double-blind trial.
At the end of the study, irritability scores decreased similarly in both groups, from 32.2 to 21.7 in the CBD group, and from 30 to 19.2 in the placebo group, with no significant difference.
The side effects were also similar, such as diarrhea, fatigue and vomiting, and appeared in 63% of children in the CBD group versus 61% in the placebo group.
However, a temporary elevation in liver enzymes was slightly more common in CBD recipients, especially when used with the epilepsy drug sodium valproate.
The results raise questions about the feasibility of relying on CBD in these cases, given its cost and potential drug interactions, compared to the lack of clear evidence of its superiority over a placebo.
Medically, cannabidiol (CBD)—a non-psychoactive compound, unlike tetrahydrocannabinol (THC), which is responsible for the psychoactive effects of cannabis—is being studied for its potential impact on the nervous system and its role in regulating certain signals associated with pain, inflammation, anxiety, and seizures. Research has shown promising results in some applications. However, despite its potential to alleviate certain symptoms, evidence remains limited regarding its effectiveness in treating severe behavioral disorders in children and adolescents, particularly since its effects and risks vary depending on the dosage and the individual's health condition.
what is your opinion on this news ?do let us know in the comments on tha comment box
if you liked this news article please share on friends & family & don't forget to follow on website & social media


